Format

Send to

Choose Destination
Ann Oncol. 2016 Aug;27(8):1652-3. doi: 10.1093/annonc/mdw189. Epub 2016 May 30.

Reply to 'Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents' by Saad and Buyse.

Author information

1
Department of Medical Oncology, Admiraal de Ruyter hospital, Goes, The Netherlands h.vanhalteren@adrz.nl.
PMID:
27241134
DOI:
10.1093/annonc/mdw189
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center